HomeRDHL • NASDAQ
add
RedHill Biopharma Ltd
Previous close
$1.19
Day range
$1.14 - $1.20
Year range
$1.01 - $8.36
Market cap
5.32M USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.04M | 58.59% |
Operating expense | 3.42M | -28.76% |
Net income | -2.07M | -33.84% |
Net profit margin | -101.32 | 15.61% |
Earnings per share | — | — |
EBITDA | -2.10M | 47.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.87M | -60.62% |
Total assets | 18.38M | -16.57% |
Total liabilities | 22.79M | 3.75% |
Total equity | -4.41M | — |
Shares outstanding | 1.80M | — |
Price to book | -0.49 | — |
Return on assets | -29.78% | — |
Return on capital | 130.36% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.07M | -33.84% |
Cash from operations | -2.51M | 18.92% |
Cash from investing | -2.00K | -300.00% |
Cash from financing | 1.63M | -58.75% |
Net change in cash | -875.50K | -202.52% |
Free cash flow | -1.48M | 48.61% |
About
Founded
2009
Website
Employees
35
